These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 2125251

  • 21. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP, Sakariassen KS, Nievelstein PF, Sixma JJ.
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [Abstract] [Full Text] [Related]

  • 22. Changes in the levels of factor VIII and von Willebrand factor in the puerperium.
    Huq FY, Kulkarni A, Agbim EC, Riddell A, Tuddenham E, Kadir RA.
    Haemophilia; 2012 Mar; 18(2):241-5. PubMed ID: 21951573
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
    Catto AJ, Carter AM, Barrett JH, Bamford J, Rice PJ, Grant PJ.
    Thromb Haemost; 1997 Jun; 77(6):1104-8. PubMed ID: 9241740
    [Abstract] [Full Text] [Related]

  • 25. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V, Marino R, Scaraggi FA, Di Bari L, Giannoccaro F, Petronelli M, Ranieri P, Tannoia N, Schiraldi O.
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [Abstract] [Full Text] [Related]

  • 26. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A, Pontara E, Dannhäuser D, Bertomoro A, Sartori MT, Girolami A.
    Haematologia (Budap); 1994 Oct; 26(2):97-109. PubMed ID: 7890268
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
    Viswabandya A, Mathews V, George B, Nair SC, Baidya S, Mammen JJ, Chandy M, Srivastava A.
    Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
    [Abstract] [Full Text] [Related]

  • 30. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
    Lubetsky A, Schulman S, Varon D, Martinowitz U, Kenet G, Gitel S, Inbal A.
    Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
    [Abstract] [Full Text] [Related]

  • 31. Possible involvement of Von Willebrand factor in pancreatic graft thrombosis after kidney-pancreas transplantation: a retrospective study.
    Kessler L, Wiesel ML, Boudjema K, Lutun E, Moulin B, Cazenave JP, Wolf P, Pinget M.
    Clin Transplant; 1998 Feb; 12(1):35-42. PubMed ID: 9541421
    [Abstract] [Full Text] [Related]

  • 32. Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens.
    van Marion AM, Auwerda JJ, Lisman T, Sonneveld P, de Maat MP, Lokhorst HM, Leebeek FW.
    Leuk Res; 2008 Jul; 32(7):1078-84. PubMed ID: 18241919
    [Abstract] [Full Text] [Related]

  • 33. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Koutts J, Baccala M, Rowell J, Baker R.
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [Abstract] [Full Text] [Related]

  • 34. Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor.
    Casonato A, Pontara E, Bertomoro A, Cattini MG, Soldera C, Girolami A.
    Haematologica; 2003 Jun; 88(6):688-93. PubMed ID: 12801845
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Impact of factor VIII and von Willebrand factor plasma levels on cerebral venous and sinus thrombosis: are they independent risk factors?
    Shahsavarzadeh T, Javanmard SH, Saadatnia M.
    Eur Neurol; 2011 Jun; 66(4):243-6. PubMed ID: 21967990
    [Abstract] [Full Text] [Related]

  • 38. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
    Ay C, Thom K, Abu-Hamdeh F, Horvath B, Quehenberger P, Male C, Mannhalter C, Pabinger I.
    Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307
    [Abstract] [Full Text] [Related]

  • 39. Von Willebrand Factor and Factor VIII levels in Egyptian children with newly diagnosed acute lymphoblastic leukemia in relation to peripheral blast cells and steroid therapy.
    El Sherif NH, Narouz MF, Elkerdany TA, El Habashy SA.
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):518-23. PubMed ID: 25105915
    [Abstract] [Full Text] [Related]

  • 40. Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke.
    Samai A, Monlezun D, Shaban A, George A, Dowell L, Kruse-Jarres R, Schluter L, El Khoury R, Martin-Schild S.
    Stroke; 2014 Sep; 45(9):2789-91. PubMed ID: 25028444
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.